Two Surveys Raise Questions about Willingness of Consumers to Pay Pathology Laboratories for Expensive Genetic Cancer Tests

This finding is reinforced by the fact that high-deductible health plans are now the second most popular plan option offered by the nation’s employers Getting paid for expensive genetic cancer tests is likely to be tougher for clinical laboratories when the patient is covered by a high-deductible health plan. There are two trends that are contributing to this situation, each highlighted by recently-published studies. One trend is the rapid growth of consumer-driven health plans (CDHPs). The...

Companion Direct Point of Care System Helps Doctors Collect Payment Quickly

With more and more consumers participating in high-deductible health plans, health savings accounts, and other forms of consumer-directed health plans, physicians and laboratories have to collect substantially more money from their patients. Collecting from patients while they are still in the physician’s office is the ideal situation, but must patients don’t know what their copayment, deductible, or out-of-pocket is for any given service. In many cases, that means that the physician must bill...

Kaiser Permanente Responds to CDHP Trend by Offering First-Ever Non-HMO Products

Kaiser Permanente has taken the radical step of introducing a new suite of consumer-driven products called Custom Care. This is the first time, since its founding more than 60 years ago, that Kaiser Permenante is offering a health insurance plan that is not based on its staff-model HMO. For lab directors and pathologists, this is an important sign of the steadily-increasing importance of consumer-directed health plans (CDHPs) in the American healthcare marketplace. Kaiser Permanente first...
;